Table 5 Summary of Findings. This table presents a summary of the findings of this overview of SRs. It summarises the 20 recommendations of the Levy et al. (2020) [8] and the Forget et al. (2022) [2] consensus statements, states the presence or not of relevant SRs and/or meta-analyses, and the respective degree of certainty (“Uncertain” in the absence of SR)
Recommendation domain | SRs/meta-analysis quality | Degree of certainty |
|---|---|---|
Levy et al.’s (2020) [8] priorities | ||
Risks with opioids | 1 SR with MA (critically low quality) | Low |
Preoperative optimisation | 2 SRs with MA + 1 SR without MA (high – critically low quality) | High – low |
Functional outcomes-based analgesia | 1 SR without MA (low quality) | Low |
Multimodal analgesia | 1 SR without MA (quality could not be assessed) | Uncertain |
Long-acting opioids | No SRs | Uncertain |
Patient-centred treatment duration | 2 SRs without MA (critically low quality) | Low |
Post-discharge repeat prescriptions | No SRs | Uncertain |
Opioid-induced ventilatory impairment | No SRs | Uncertain |
Modifiable factors | No SRs | Uncertain |
Safe opioid storage and disposal | 3 SRs without MA (critically low quality | Low |
Forget et al.’s (2022) [2] priorities | ||
Opioid Stewardship Steering Committee | 1 SR without MA (critically low quality) | Low |
Safe and accountable opioid use policies | No SRs | Uncertain |
Policies on opioid prescriptions determinants | No SRs | Uncertain |
Opioid treatment (dose and duration) policies | 1 SR with MA (low quality) | Low |
Follow-up and referral guidelines | No SRs | Uncertain |
Monitoring of opioid prescriptions | No SRs | Uncertain |
Preventing obstacles to access appropriate opioid prescription | No SRs | Uncertain |
Opioid disposal | No SRs | Uncertain |
Benchmarking | No SRs | Uncertain |
Improved interaction primary/secondary care | No SRs | Uncertain |